Prescription medication · ACE Inhibitor
ramipril
Also sold as Altace. Ramipril is used to treat high blood pressure.
Data updated 2026-05-15
- 119,507
- FDA reportsOften reported
- 11
- InteractionsSeveral interactions
- 99% less
- Generic vs brandHuge savings
- 1
- Recall record
What the data shows
ramipril (Altace) is a prescription ACE Inhibitor, more reported than most tracked drugs (119,507 FDA reports), whose generic costs a fraction of the brand (about 99% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
ramipril (Altace) is a prescription ACE Inhibitor. Ramipril is used to treat high blood pressure.
Ramipril is a medicine that lowers blood pressure. It can also help people with heart failure after a heart attack.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$7.43/unit
Generic Price
$0.09/unit
Generic Savings
99%
Generic Available
Yes (6 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Ramipril is used to treat high blood pressure.
Common side effects
Headache, Dizziness, Fatigue
Key warnings
This drug can cause serious harm or death to an unborn baby.
The sections below are summarized in plain English from ramipril's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Ramipril belongs to a class of drugs called ACE inhibitors. It works by blocking a substance in your body that tightens blood vessels. This helps your blood vessels relax and lowers your blood pressure.
Side Effects (from patient reports)
Based on 119,507 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for ramipril, by number of reports
- Dyspnoea
Dyspnoea
8,083 reports
- Fatigue
Fatigue
7,877 reports
- Nausea
Nausea
7,339 reports
- Diarrhoea
Diarrhoea
6,913 reports
- Dizziness
Dizziness
6,526 reports
- Vomiting
Vomiting
6,055 reports
- Pain
Pain
5,656 reports
- Headache
Headache
5,363 reports
- Acute Kidney Injury
Acute Kidney Injury
5,292 reports
- General Physical Health Deterioration
General Physical Health Deterioration
5,162 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for ramipril each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where ramipril sits
ramipril has more FDA adverse-event reports than 88% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is ramipril; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 119,507 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.
Total Reports
119,507
Reports Mentioning Death
12,637
10.6% of reports — not proof of cause
Hospitalization Reports
62,948
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DYSPNOEA | 8,083 |
| 2 | FATIGUE | 7,877 |
| 3 | NAUSEA | 7,339 |
| 4 | DIARRHOEA | 6,913 |
| 5 | DIZZINESS | 6,526 |
| 8 | VOMITING | 6,055 |
| 9 | PAIN | 5,656 |
| 10 | HEADACHE | 5,363 |
| 11 | ACUTE KIDNEY INJURY | 5,292 |
| 12 | GENERAL PHYSICAL HEALTH DETERIORATION | 5,162 |
| 13 | ASTHENIA | 5,044 |
| 14 | MALAISE | 4,937 |
| 15 | ARTHRALGIA | 4,915 |
| 16 | FALL | 4,895 |
| 17 | HYPERTENSION | 4,780 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
This drug can cause serious harm or death to an unborn baby. If you are pregnant or plan to become pregnant, tell your doctor right away. Stop taking ramipril as soon as you know you are pregnant.
Known Drug Interactions
Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.
Mechanism: Both of these medicines can cause your body to hold onto potassium, which may lead to dangerously high potassium levels in your blood.
In a large-scale, long-term clinical efficacy study, the combination of telmisartan and ramipril resulted in an increased incidence of clinically important renal dysfunction (death, doubling of serum creatinine, dialysis) compared with groups receiving either drug alone. Therefore, concomitant use of telmisartan and ramipril is not recommended [see Dual Blockade of the Renin-Angiotensin-Aldosterone System ( 5.7 ) ].
Mechanism: Taking these two types of blood pressure medicines together can put too much stress on your kidneys and increase the risk of kidney damage.
• Lithium: Use with caution ( 7.3 ). 7.3 Lithium Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium; therefore, frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased.
Mechanism: Ramipril can make it harder for your kidneys to remove lithium from your body, which can cause lithium to reach toxic levels.
Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.
Mechanism: Both of these drugs cause your body to hold onto potassium instead of getting rid of it through your urine. This can lead to a dangerous buildup of potassium in your blood.
7.6 Other Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin.
Mechanism: These two medicines do not have any known effect on how the other one works or is processed.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take ramipril with other medications?
What should I avoid while taking ramipril?
How long does it take for ramipril to work?
Can I stop taking ramipril if I feel better?
Does ramipril have any effect on my kidneys?
Can ramipril cause angioedema?
Can I drink alcohol while taking ramipril?
What if I have diarrhea or vomiting while taking ramipril?
Can ramipril cause a cough?
Are there any long-term side effects of ramipril?
What are the common side effects of ramipril?
Does ramipril interact with other medications?
What drug class is ramipril?
Is there a generic version of ramipril?
What pregnancy or breastfeeding source fields are listed for ramipril?
Has ramipril been recalled?
Active Recalls
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Actavis Laboratories, FL, Inc.
Related Medications in ACE Inhibitor
Other drugs grouped near ramipril - same-class peers and common alternatives.
acebutolol
Sectral
Acebutolol is a medicine that helps lower blood pressure and control irregular heartbeats.
Compare with ramipril →
aliskiren
Tekturna
Tekturna is a medicine used to treat high blood pressure.
Compare with ramipril →
amiloride
Midamor
Amiloride is a water pill that helps your body hold onto potassium.
Compare with ramipril →
amlodipine
Norvasc
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain.
Compare with ramipril →
amlodipine/benazepril
Lotrel
Lotrel is a combination medicine that contains amlodipine and benazepril.
Compare with ramipril →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for ramipril: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 119,507.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 10.57%.
- metronidazole Δ 0.02 pts · 63,731 reports · Nitroimidazole Antibiotic 10.56%death share
- nizatidine Δ 0.03 pts · 1,480 reports · H2 Receptor Antagonist 10.61%death share
- tretinoin Δ 0.04 pts · 7,629 reports · Retinoid (Topical) 10.54%death share
- alogliptin Δ 0.08 pts · 3,393 reports · DPP-4 Inhibitor 10.49%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ramipril
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ramipril
The FDA label for ramipril (sold under brand names such as Altace) classifies it as a prescription-only medication in the ACE Inhibitor class. Ramipril is used to treat high blood pressure. Official labeling lists 4 commonly reported side effects, including Headache, Dizziness, Fatigue.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 119,507 voluntary reports. The database also lists 11 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.09 versus $7.43 for the brand - a 99% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 1 recall record on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: July 1, 2022
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages